Direct answer: MaleMD advertised injections and mint dissolvable tablets for $149 per month on July 21, 2026. Its page said a medical evaluation, shipping, and support were included. That is a promotional snapshot, not a permanent all-in guarantee. The breakdown below separates what the offer states from what it leaves unpriced.
What the advertised price appears to include
The public offer lists the same monthly promotional price for an injectable formulation and a mint dissolvable tablet. For injections, the page describes one vial, an injection kit, and approximately one month of supplies. For tablets, it describes a daily dissolvable formulation. Both are presented as prescription options prepared through licensed United States pharmacies.
The page also states that the treatment plan includes a medical evaluation, shipping, and support. It does not clearly itemize every possible laboratory or follow-up charge in the price block. Before submitting payment, capture the checkout page and ask for a written list of included services.
The price is tied to recurring billing
MaleMD’s Terms of Service describe a subscription that remains active until canceled. The valid card on file may be charged with each shipment, either monthly or every two months depending on the election. The terms also allow the company to change fees with advance notice and distinguish promotional offers from standard pricing.
This means the useful number is not only the first payment. Record the renewal amount, charge date, shipment frequency, promotion duration, and cancellation cutoff. Read the posted cancellation and refund policy before the first order, not after a charge appears.
Build the complete cost stack
| Cost layer | Public-page position | Question to ask |
|---|---|---|
| Medication plan | $149 monthly promotional price on the verification date | What is the nonpromotional renewal price? |
| Initial evaluation | Described as included | Is any live or follow-up visit billed separately? |
| Laboratory testing | Not clearly itemized in the offer block | Which baseline and follow-up tests are required, and who pays? |
| Shipping | Described as included | Do rush, replacement, or address-change shipments cost extra? |
| Injection supplies | Kit described as included with injections | Which supplies arrive and how are sharps disposed of locally? |
| Support | Described as available | Does this mean administrative help, clinician messaging, or both? |
| Cancellation risk | Cancellation required before the next shipment | What exact date and time is the cutoff? |
Laboratory cost is a clinical question too
A low headline price is not better value if the evaluation or monitoring plan is unclear. Endocrine Society guidance says suspected adult growth hormone deficiency usually requires proper stimulation testing, with limited exceptions. A single symptom or isolated IGF-1 result does not automatically establish the diagnosis.
Ask the clinician which tests are medically indicated, what each test will change, where the specimen can be collected, and whether insurance billing or cash payment applies. Do not buy a broad panel simply because it is marketed as an “optimization” package. Testing should answer a defined clinical question.
Monitoring may also create indirect costs, including time away from work, travel to a laboratory, repeat collection, or a visit with a local clinician. Those costs belong in the comparison even when MaleMD does not collect them.
How openly those costs are disclosed also varies from one provider to the next. Hone Health, Ro, and Hims and Hers each present pricing in their own way, and a service such as HealthRX publishes its peptide therapy pricing and the clinical details behind it on the page itself. A number you can read before enrolling is easier to compare than one reconstructed from a monthly figure, and none of these prices signals anything about a compounded product’s quality.
Insurance, HSA, and FSA are different questions
MaleMD states that insurance is not required and displays HSA/FSA payment language. That does not mean a health plan covers the medication or that every purchase qualifies for tax-advantaged reimbursement. Insurance coverage, card acceptance, and tax eligibility are separate determinations.
Current compounded Sermorelin products are not FDA approved. The earlier Geref products had approvals for specific pediatric and diagnostic uses, then were discontinued and their approvals withdrawn. That history does not create automatic coverage for a compounded adult wellness prescription.
For insurance, call the plan using the number on the member card. Provide the exact product, dispensing pharmacy, prescriber, and proposed diagnosis. Ask about exclusions for compounded drugs, telehealth programs, investigational care, and out-of-network laboratories. For HSA or FSA questions, retain an itemized receipt and consult the plan administrator or a qualified tax professional.
Price per month is not the same as value
Two programs with the same monthly price can provide different formulations, clinical review, laboratory access, pharmacy transparency, shipping protection, and follow-up. Even the same peptide name does not make products equivalent. The price comparison should begin only after clinical appropriateness and product identity are understood.
Several cash-pay programs quote sermorelin, and their published numbers are not measuring the same thing. Marek Health, Invigor Medical, and FormBlends, a physician-supervised provider that lists peptide pricing openly, each present a monthly figure, and the only useful comparison is what sits inside each figure. All of them are dispensing a compounded product that has not been through FDA approval, so price differences say nothing about product quality.
FDA explains that compounded drugs do not undergo the agency’s premarket review for safety, effectiveness, or quality. A higher price does not prove better quality, and a lower price does not prove poor quality. Verify the dispensing pharmacy, label, storage instructions, lot information, and process for reporting a product problem.
The strongest value signal is a program that explains why treatment is proposed, names the responsible clinician and pharmacy, defines measurable goals, responds to adverse symptoms, and makes the financial terms easy to retrieve. Marketing benefits and testimonial volume are weaker signals. A convenient purchase path cannot substitute for a defensible medical rationale.
Also price the decision to stop. A person may pay for a final shipment that was prepared before a cancellation took effect, an outside laboratory visit, disposal of unused supplies, or local care for a problem that telehealth cannot assess. These possibilities are not predictions about MaleMD. They are ordinary transaction and care costs that a realistic budget should leave room for. When comparing programs, note which costs are fixed, which are conditional, and which can be avoided by acting before the next fulfillment date. A simple spreadsheet with the source, verification date, amount, payment timing, and cancellation rule is more reliable than memory or an advertising headline.
Five checks before checkout
- Take a dated screenshot of the offer, formulation, and final checkout amount.
- Write down the next billing date, renewal price, shipment frequency, and cancellation cutoff.
- Ask whether any laboratory, follow-up, replacement, or supply fee is excluded.
- Confirm the pharmacy and prescriber can be verified independently.
- Decide what clinical outcome and safety information would justify continuing.
Apply those same five checks to every program under consideration so an introductory price does not dominate the decision.
Frequently asked questions
Is the first month a trial?
The public offer is presented as a subscription, not a risk-free clinical experiment. Verify whether any minimum term applies and remember that shipped prescription products fall under the posted no-refund rule.
Can the price change?
Yes. The terms reserve the right to change pricing with advance notice and note that promotions may differ. Keep copies of notices and account screens.
What if the clinician does not approve treatment?
Ask when the card is charged and what happens if no prescription is issued. The sales page says a licensed clinician determines appropriateness, so approval should never be assumed.
Should the cheapest provider win?
No. Compare diagnosis, monitoring, formulation, pharmacy, support, policy clarity, and total cost together.
